I am taking mine up because I want the options. Debating about whether to buy on market as well.
In summary:
As per 39KP, PR completely mismessaged this and therefore retail is/was pissed off. Meanwhile insiders/shorters have profited from this.
As per Denial, I believe this cap raise is a function of delayed trial results. MPS VI final recruit delayed results by about 3-4 months. OA deal wasn't going to be done before 008 results. Increase in costs from more centres opening in U.S. and balance sheet under pressure = cr.
Not happy with governance but big believer in the drug and that deals get done in the next 6 months. Could be wrong. As * said, regrowth of cartilage is like adults growing teeth.
PAR Capital Position and 2024 Raising Requirements, page-104
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 429247 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 13806 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |